Anteris Technologies Global Corp. CHESS Depositary Interest (AVR)

Overview

Anteris Technologies Ltd is a pioneering structural heart company based in Toowong, Australia, engaged in the design, development, and commercialization of innovative medical devices. The company, established in 1999, initially operated under the name Admedus Limited until its rebranding to Anteris Technologies Ltd in May 2020. With its rich history and a clear focus on leveraging cutting-edge technology to improve patient outcomes, Anteris has positioned itself as a leader in the field of regenerative tissue products and transcatheter heart valves.

Products and Services

• ADAPT

  ADAPT is a ground-breaking regenerative tissue product manufactured and sold by Anteris Technologies. This product is at the forefront of medical innovation, providing solutions that significantly advance the treatment of structural heart conditions. ADAPT's unique properties make it a highly sought-after component in various therapeutic devices, underscoring Anteris's commitment to developing products that regenerate life.

• DurAVR™

  The DurAVR™ valve represents a significant advancement in the treatment of aortic stenosis, a common and serious heart condition. As a transcatheter heart valve, DurAVR™ allows for minimally invasive treatment, offering patients a safer and less painful alternative to traditional surgical options. With its cutting-edge design and superior materials, the DurAVR™ valve is a testament to Anteris's dedication to pushing the boundaries of medical technology and improving patient care.